Get the Stockscreener App
70.33
2.05%
1.41
Tempus Ai Inc stock is traded at $70.33, with a volume of 4.84M.
It is up +2.05% in the last 24 hours and up +3.26% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$68.92
Open:
$69.5
24h Volume:
4.84M
Relative Volume:
0.93
Market Cap:
$12.51B
Revenue:
$803.32M
Net Income/Loss:
$-709.10M
P/E Ratio:
-9.0163
EPS:
-7.8003
Net Cash Flow:
$-212.68M
1W Performance:
+6.13%
1M Performance:
+3.26%
6M Performance:
+17.28%
1Y Performance:
+102.39%
1-Day Range:
$68.57
$71.88
1-Week Range:
$66.08
$76.33
52-Week Range:
$34.35
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
70.33 | 12.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
VEEV
Veeva Systems Inc
|
222.21 | 35.99B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
DOCS
Doximity Inc
|
41.26 | 7.73B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
85.37 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.20 | 7.14B | 11.99B | 24.18M | 234.31M | 0.2956 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Top Artificial Intelligence Stocks To Add to Your WatchlistJanuary 15th - MarketBeat
Best Artificial Intelligence Stocks To Watch NowJanuary 6th - MarketBeat
Tempus AI, Inc. Stock (TEM) Opinions on FDA Clearance and Financial Results - Quiver Quantitative
JPM26: Tempus AI and the push toward precision medicine - Yahoo Finance
Tempus AI approaching profitability despite GAAP losses - MSN
Why is Tempus AI stock surging 11% premarket today? - MSN
4 Hyper-Growth Stocks Ready to Dazzle This Earnings Season - Investing.com
Jobs Data: Is Tempus AI Inc stock a value trapPortfolio Growth Summary & High Return Trade Guides - baoquankhu1.vn
New Highs: Is Tempus AI Inc stock a value trapJuly 2025 Action & Fast Gaining Stock Reports - baoquankhu1.vn
Promising Artificial Intelligence Stocks To Watch TodayJanuary 13th - MarketBeat
Promising Artificial Intelligence Stocks To Follow TodayJanuary 4th - MarketBeat
Tempus AI (TEM) Soars 15% on $1.1-Billion Deal - Insider Monkey
TEM's Collab for Oncology Patient Population Is Gaining Attention - Yahoo Finance Singapore
Tempus AI, Inc. $TEM Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Lefkofsky sees more runway ahead for now-profitable Tempus - Crain's Chicago Business
SG Americas Securities LLC Sells 15,137 Shares of Tempus AI, Inc. $TEM - MarketBeat
Is Tempus AI (TEM) Pricing Reflect Its AI Healthcare Story After Strong 1 Year Run? - Yahoo Finance
Tempus AI achieved a record $1.1B in contracts for 2025 - Investorsobserver
Nvidia and Tempus drive AI transformation in Korea-linked drug discovery and manufacturingCHOSUNBIZ - Chosunbiz
Why Tempus AI Stock Rose Today - Finviz
Record 2025 Revenue and New Cancer Data Deals Might Change The Case For Investing In Tempus AI (TEM) - simplywall.st
Why Tempus AI stock rose today - MSN
JPM26, Day 1: Waystar rolls out agentic AI; Intermountain CEO addresses political upheaval - Fierce Healthcare
JPM Kicks Off With Alnylam In the Red; But Others Surge - Investor's Business Daily
Tempus AI (NASDAQ:TEM) Shares Gap UpStill a Buy? - MarketBeat
Why Tempus AI Stock Is Trading Higher On Monday? - Benzinga
Why Tempus AI Stock Jumped on Monday? - GuruFocus
Tempus Shares Jump After Strong Preliminary 2025 Results - Yahoo Finance
Tempus AI's Pharma Momentum Accelerates - GuruFocus
Northwestern Medicine Selects Tempus AI, Inc. to Expand Genomic Testing - marketscreener.com
Tempus and NYU Langone partner on cancer genomic research - Investing.com
Tempus and NYU Langone partner on cancer genomic research By Investing.com - Investing.com South Africa
Promising Artificial Intelligence Stocks To Keep An Eye OnJanuary 12th - MarketBeat
Here’s why the Tempus AI stock may surge 47% soon - CryptoRank
Nancy Pelosi's Latest Trades Are Heating Up — Tempus AI's 100% Stock Surge Is Leading The Charge - Benzinga
Tempus AI rises on better-than-expected sales numbers - Sherwood News
Tempus Pre Announcing Strong Data (NASDAQ:TEM) - Seeking Alpha
Tempus AI shares jump after company posts record $1.1BN contract backlog - MSN
Why Is Tempus AI Stock Surging 11% Premarket Today? - Menafn
Tempus AI stock pops 12% premarket after $1.1 billion contracts update — what traders watch next - TechStock²
AI and cancer: how Tempus and NYU Langone team up to study tumors over time - Stock Titan
Tempus AI (TEM) Stock: Why Big Pharma Is Betting Big on This AI Platform - Blockonomi
Tempus AI Stock Rallies 105% in a Year: Should Investors Still Hold? - Yahoo Finance
Northwestern Medicine and Tempus partner to expand cancer genomic testing - Investing.com Canada
S&P 500 Futures Fall in Premarket Trading; Tempus AI, Klarna Group Lead - Barron's
Northwestern Medicine and Tempus partner to expand cancer genomic testing By Investing.com - Investing.com South Africa
Tempus AI stock soars after achieving record $1.1 billion contract value - Investing.com Nigeria
Tempus AI stock soars after achieving record $1.1 billion contract value By Investing.com - Investing.com South Africa
Northwestern Medicine Selects Tempus to Expand Genomic Testing - The Joplin Globe
Tempus AI Reports Strong Preliminary 2025 Revenue Growth - TipRanks
Tempus AI climbs on $1.1 billion contract value - TradingView — Track All Markets
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.51%
1.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):